News|Articles|January 30, 2025
UpTempo Plasmid DNA Platform: Single-Use Innovation for the Future of Therapeutic Manufacturing
Author(s)Catalent
Plasmid DNA (pDNA) is a critical starting material used to manufacture viral and nonviral cell and gene therapies (CGT).
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
4
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
5
